Integrating clinical research in Europe
Last changed:08.11.2011



ECRIN-Eric is currently searching for its office based in Paris (France) a Quality Manager and a Communication Officer.

Deadline to receive applications: 3rd November 2014.

To learn more about:

Quality Manager Application

Communication Officer Application

Database on outcome measures for medical device trials online now!

Selecting appropriate outcome measures to assess the efficacy and safety of a medical device in a given disease plays a crucial role and can be challenging. A database that allows you to search information on relevant outcomes related to specific medical devices is established and is now available to support you in planning, conducting clinical trials and health technology assessments (HTA) on medical devices.

For more information and link to the data base, please look at the section tools.

Czech Republic signs up to ECRIN

The ECRIN-ERIC Assembly of Members approved on the 8th July 2014, the application of Czech Republic as an Observer in ECRIN-ERIC.

Czech Republic becomes the sixth country joining ECRIN-ERIC.

Mr Jan Buriánek will represent the Czech Ministry of Education, Youth and Sports at the Assembly of Members.

The scientific partner, CZECRIN, will be represented at the ECRIN-ERIC network committee by Dr Regina Demlova.


ECRIN-Eric is currently searching for its office based in Paris (France) a Capacity Director, a Director of Clinical Operations and a Legal and Regulatory Officer.

Deadline to receive applications: 3rd July 2014.

To learn more about:

Capacity Director Application

Director of Clinical Operations Application

Legal and Regulatory Officer Application

Collaboration Memorandum of Understanding with Therapeutic lnnovation Australia Ltd (TlA)

A collaboration memorandum of understanding was signed on May 8th, during a ceremony at the Australian Embassy in Brussels, between Therapeutic Innovation Australia Ltd (TIA, represented by its CEO Stewart Hay) and ECRIN-Eric (represented by Jacques Demotes, Director General, and Rafael de Andres, Chair of the Assembly of Members). This collaboration memorandum of understanding aims at fostering international collaboration on clinical trials between Europe and Australia, through the development of shared tools, particularly regulatory awareness, quality, training and monitoring strategies, and through a coordinated support to international trials, taking advantage of the capacity of each party to manage regional studies.

See more...


SCTO Symposium 2014: "Is there a future for Swiss clinical research?"

18 June 2014 | Inselspital, Bern University Hospital

The 5th Annual Symposium of the Swiss Clinical Trial Organisationour is dedicated to the subject “Is there a future for Swiss Academic Clinical Research?”  and will take place on 18 June 2014 at the Inselspital Bern. Representatives from patient organisations, academic institutions, industry as well as authorities will discuss their views and visions.

More at

Clinical Research Informatics Solution Days 2014

26th and 27th May 2014, Düsseldorf, Germany

A two days workshop with interactive sessions and demonstrations to be held on 26th and 27th May 2014 in Düsseldorf, Germany and organized by ECRIN together with other EU-funded projects (TRANSFoRm, EHR4CR, p-medicine, BioMedBridges and ECRIN-IA) to bring together experts, users and innovators from the clinical research domain. For more information we suggest to have a look at CRI Solutions Days.

<< First < Previous 1-7 8-14 15-21 Next > Last >>


EFGCP Workshop on Quality Risk Management in Clinical Trials: Demonstrating How to Implement Risk-Based Monitoring

16 & 17 June 2014
University College London, United Kingdom

The workshop is being developed in close collaboration with thought-leaders from Health Authorities, industry, CROs, academia and patients representatives. Up to now discussions on risk management have been mainly theoretical and the practicalities of 'how to' has not been defined. Yet nobody is sure how much is actually 'enough' and how much is too little. Research Organisations are starting to create their approaches to risk assessment and risk-based monitoring and yet there are still questions which need to be addressed, especially on how to define, justify and "validate" of what is critical to patients' safety, integrity & rights, and data integrity. At the end of the workshop a discussion round with regulators is planned to give participants guidance whether the approaches developed during the workshop would be acceptable in their view.

Read more about.

Download the programme.

EFGCP Annual Conference 2014: "Benefits and Risks of Research: How Do We Redress the Current Imbalance?"

28 & 29 January 2014 - Renaissance Brussels Hotel, Brussels, Belgium

The risks and benefits of research remain a central consideration in drug development, research design, review and regulation. It’s consequently a central concern within the new proposed EU Clinical Trial Regulations...

Download the agenda

Find more on


Naples, December 13th, 2013

A meeting organised by the Alessandro Liberati - Italian Cochrane Network on transparency in clinical research.

Download the programme.


ECRIN Annual Meeting 2013

May 16, 2013, Medical University of Warsaw, Poland

As every year ECRIN working parties, European Correspondents and the Network Committee will meet together at the annual meeting. The 2013 edition will be held on May 16th 2013 in Warsaw, Poland.

The meeting will be preceded by breakout sessions for the different Work Packages, organized and led by the WP leaders on May 15th in the afternoon and on May 16th in the morning.

Download the agenda

The celebration of the 2012 International Clinical Trials Day in Spain

May 22-25, 2012

The celebration of the 2012 International Clinical Trials Day, organized for the first time in Spain, was a unique opportunity to initiate a broader partnership between the industry, regulators, hospitals and patients’ associations Quintiles Spain hosted key stakeholders at a three-day conference centered on the practice of the clinical research.

Read more

ECRIN Annual Meeting 2012

May 17, 2012, Dublin Castle, Dublin, Ireland

ECRIN working parties, European Correspondents and the Network Committee will meet on Thursday 17th of May 2012 in Dublin, Ireland.

There will be also the WP2 meeting (see the agenda) and the WP5 breakout session on May 16th afternoon, and several breakout sessions involving the WP2-3-4-5-6 on May 17th.

Download the agenda

Kick-off meeting of the new ECRIN-IA (Integrating activities) project

January 19, 2012, Résidence Palace, Brussels, Belgium


All the partners of the project will meet on Thursday 19 January 2012 at the Residence Palace in Brussels, Belgium for the launch of the new project and to discuss in depth the activity in the different workpages.

The objective of ECRIN IA is to expand ECRIN partnership and to develop in the following areas:

- expanding the network and strengthening its national partners

- supporting cross-border connection of investigation networks

- creating a common European culture among professionals and patients communities

- further developing data management and monitoring tools for multinational trials

- and making funding available for multinational clinical research projects.

The ECRIN-IA project will take advantage of the organisation, know-how, competences, procedures and tools already developed by ECRIN, and of the management of the ECRIN-ERIC.

Networking activities will promote pan-European expansion, capacity building, and partnership with other world regions, and address the funding issue (WP2). ECRIN-IA will develop e-services, education material to train professionals and patients associations, and communication with users, patients, citizens and policymakers (WP3). It will support the structuring and connection to ECRIN of disease-, technology-, or product-oriented investigation networks and hubs focusing on specific areas: rare diseases (WP4), medical device (WP5), and nutrition (WP6).

Transnational access activities will support the cost of multinational extension of clinical trials on rare diseases, medical device and nutrition selected by the ECRIN scientific board (WP7).

Joint research activities are designed to improve the efficiency of ECRIN services, through the development of tools for risk-adapted monitoring (WP8), and the upgrade of the VISTA data management tool (WP9).

The tools developed tools will improve the quality and enlarge the spectrum of services proposed by ECRIN, and will also benefit to the investigator networks as well as to the newly connected countries.

This project will build a consistent organisation for clinical research in Europe, with ECRIN developing generic tools and providing generic services to multinational studies, and supporting the construction of pan-European disease-oriented networks that will in turn act as ECRIN users and provide the scientific content. Such organisation will improve Europe’s attractiveness for industry trials, boost its scientific competitiveness, and result in better healthcare for European citizens.

Download the agenda


<< First < Previous 1-7 8-10 Next > Last >>

Latest News


ECRIN-Eric is currently searching for its office based in Paris (France) more

Database on outcome measures for medical device trials online now!

Selecting appropriate outcome measures to assess the efficacy and safety more

Czech Republic signs up to ECRIN

The ECRIN-ERIC Assembly of Members approved on the 8th July 2014, the more

Latest published Article

ECRIN et la structuration de la recherche clinique en Europe

Jacques Demotes-Mainard

The article presents the role of ECRIN (European more

Internal Section

Forgot your password?

Last changed:08.11.2011